Literature DB >> 19910631

Natural killer T cells are involved in adipose tissues inflammation and glucose intolerance in diet-induced obese mice.

Kazue Ohmura1, Naoki Ishimori, Yoshinori Ohmura, Satoshi Tokuhara, Atsushi Nozawa, Shunpei Horii, Yasuhiro Andoh, Satoshi Fujii, Kazuya Iwabuchi, Kazunori Onoé, Hiroyuki Tsutsui.   

Abstract

BACKGROUND: Macrophage and lymphocyte infiltration in adipose tissue may contribute to the pathogenesis of obesity-mediated metabolic disorders. Natural killer T (NKT) cells, which integrate proinflammatory cytokines, have been demonstrated in the atherosclerotic lesions and in visceral adipose tissue.
OBJECTIVE: To determine whether NKT cells are involved in glucose intolerance and adipose tissue inflammation in diet-induced obese mice. METHODS AND
RESULTS: Male beta(2)-microglobulin knockout (KO) mice lacking NKT cells and C57BL/6J (wild-type) mice were fed with a high-fat diet (HFD) for 13 weeks [corrected]. Body weight and visceral obesity were comparable between wild-type and KO mice. However, macrophage infiltration was reduced in adipose tissue and glucose intolerance was significantly ameliorated in KO mice. To further confirm that NKT cells are involved in these abnormalities, alpha-galactosylceramide, 0.1 microg/g body weight, which specifically activates NKT cells, was administered after 13 weeks of HFD feeding. alpha-Galactosylceramide significantly exacerbated glucose intolerance and macrophage infiltration as well as cytokine gene expression in adipose tissue.
CONCLUSIONS: NKT cells play a crucial role in the development of adipose tissue inflammation and glucose intolerance in diet-induced obesity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19910631     DOI: 10.1161/ATVBAHA.109.198614

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  98 in total

Review 1.  Inflammatory links between obesity and metabolic disease.

Authors:  Carey N Lumeng; Alan R Saltiel
Journal:  J Clin Invest       Date:  2011-06-01       Impact factor: 14.808

Review 2.  Immunomodulation at epithelial sites by obesity and metabolic disease.

Authors:  Kitty P Cheung; Kristen R Taylor; Julie M Jameson
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

3.  Adipose tissue inflammation and reduced insulin sensitivity in ovariectomized mice occurs in the absence of increased adiposity.

Authors:  Victoria J Vieira Potter; Katherine J Strissel; Chen Xie; Eugene Chang; Grace Bennett; Jason Defuria; Martin S Obin; Andrew S Greenberg
Journal:  Endocrinology       Date:  2012-07-09       Impact factor: 4.736

Review 4.  Nutrition and metabolic correlates of obesity and inflammation: clinical considerations.

Authors:  Amy R Johnson; Liza Makowski
Journal:  J Nutr       Date:  2015-04-01       Impact factor: 4.798

5.  Mast cell stabilization: novel medication for obesity and diabetes.

Authors:  Jing Wang; Guo-Ping Shi
Journal:  Diabetes Metab Res Rev       Date:  2011-11       Impact factor: 4.876

6.  Deficiency of lymphotoxin-α does not exacerbate high-fat diet-induced obesity but does enhance inflammation in mice.

Authors:  Nathalie Pamir; Timothy S McMillen; Kimberly A Edgel; Francis Kim; Renée C LeBoeuf
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-02-07       Impact factor: 4.310

Review 7.  Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training.

Authors:  Christian K Roberts; Andrea L Hevener; R James Barnard
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

Review 8.  Immune cells and metabolic dysfunction.

Authors:  Ashley Eheim; Dasa Medrikova; Stephan Herzig
Journal:  Semin Immunopathol       Date:  2013-11-09       Impact factor: 9.623

Review 9.  Adipose tissue inflammation in glucose metabolism.

Authors:  H L Kammoun; M J Kraakman; M A Febbraio
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

Review 10.  Adaptive immunity in obesity and insulin resistance.

Authors:  Henrike Sell; Christiane Habich; Juergen Eckel
Journal:  Nat Rev Endocrinol       Date:  2012-07-31       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.